ArticleJournal of clinical medicine2023

The Role of Anti-Factor Xa Activity in the Management of Ecchymosis in Patients Receiving Rivaroxaban after Total Knee Arthroplasty.

Han Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.